| Jay A Johnson, DO | |
|
2103 Ingersoll Ave, Des Moines, IA 50312-5262 | |
| (515) 279-6424 | |
| (515) 279-3237 |
| Full Name | Jay A Johnson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 2103 Ingersoll Ave, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497715262 | NPI | - | NPPES |
| 1497715262 | Medicaid | IA | |
| 0260901 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 3360 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Unitypoint Health - Des Moines Iowa Methodist Medi | Des moines, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iowa Physicians Clinic Medical Foundation | 8729992318 | 972 |
News Archive
Younger people are less likely to be hospitalized or die of COVID-19 than their elders, but they circulate more freely while carrying the disease, and their cases are harder to trace. Together, these facts terrify California hospital officials.
As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.
In this post in USAID's "IMPACTblog," Melissa Sharer, AIDSTAR-One senior care and support officer at John Snow, Inc., writes, "Although treatment is now widely available and people living with HIV (PLHIV) are able to live normal and active lives for many years, their mental health needs are often overlooked in care, treatment, and support programs." Sharer highlights the success of programs in Vietnam and in Uganda that "combine mental health and existing health services."
Lee Iacocca the Chief Executive Officer of Chrysler from 1978 to 1992 has announced the launch of "Join Lee Now," a fundraising initiative to investigate a potential cure for type 1 diabetes. Mr Iacocca has personally pledged $1 million to the cause.
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.
› Verified 1 days ago
| Entity Name | Iowa Physicians Clinic Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366425274 PECOS PAC ID: 8729992318 Enrollment ID: O20031118000363 |
News Archive
Younger people are less likely to be hospitalized or die of COVID-19 than their elders, but they circulate more freely while carrying the disease, and their cases are harder to trace. Together, these facts terrify California hospital officials.
As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.
In this post in USAID's "IMPACTblog," Melissa Sharer, AIDSTAR-One senior care and support officer at John Snow, Inc., writes, "Although treatment is now widely available and people living with HIV (PLHIV) are able to live normal and active lives for many years, their mental health needs are often overlooked in care, treatment, and support programs." Sharer highlights the success of programs in Vietnam and in Uganda that "combine mental health and existing health services."
Lee Iacocca the Chief Executive Officer of Chrysler from 1978 to 1992 has announced the launch of "Join Lee Now," a fundraising initiative to investigate a potential cure for type 1 diabetes. Mr Iacocca has personally pledged $1 million to the cause.
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay A Johnson, DO 2103 Ingersoll Avenue, Des Moines, IA 50312-5262 Ph: (515) 279-6424 | Jay A Johnson, DO 2103 Ingersoll Ave, Des Moines, IA 50312-5262 Ph: (515) 279-6424 |
News Archive
Younger people are less likely to be hospitalized or die of COVID-19 than their elders, but they circulate more freely while carrying the disease, and their cases are harder to trace. Together, these facts terrify California hospital officials.
As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.
In this post in USAID's "IMPACTblog," Melissa Sharer, AIDSTAR-One senior care and support officer at John Snow, Inc., writes, "Although treatment is now widely available and people living with HIV (PLHIV) are able to live normal and active lives for many years, their mental health needs are often overlooked in care, treatment, and support programs." Sharer highlights the success of programs in Vietnam and in Uganda that "combine mental health and existing health services."
Lee Iacocca the Chief Executive Officer of Chrysler from 1978 to 1992 has announced the launch of "Join Lee Now," a fundraising initiative to investigate a potential cure for type 1 diabetes. Mr Iacocca has personally pledged $1 million to the cause.
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.
› Verified 1 days ago
Neetha Molakala, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 University Ave, Suite 120, Des Moines, IA 50314 Phone: 515-248-1500 Fax: 515-248-1510 | |
Matthew Helmick Williams, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1801 Hickman Rd, Des Moines, IA 50314 Phone: 515-282-5640 Fax: 515-282-2332 | |
Todd Eberle, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-8678 Fax: 515-643-5802 | |
Evan Douglas Peterson, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6520 Se 14th St, Des Moines, IA 50320 Phone: 515-953-1500 Fax: 515-953-2136 | |
April Winters, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2353 Se 14th St, Des Moines, IA 50320 Phone: 515-248-1400 Fax: 515-248-1414 | |
Kelli A Roenfanz, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 840 East University Avenue, Des Moines, IA 50316 Phone: 515-265-4211 Fax: 515-309-5993 | |
Dr. Sarah Sweeney Gude, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3509 E 29th St, Des Moines, IA 50317 Phone: 515-248-1600 Fax: 515-248-1610 |